222 related articles for article (PubMed ID: 30654238)
21. Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis.
Li P; Wang B; Fu L; Guo K; Ma C; Wang B; Lin Z; Li G; Huang H; Lu Y
Eur J Med Chem; 2021 Oct; 222():113603. PubMed ID: 34126456
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
[TBL] [Abstract][Full Text] [Related]
23. Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.
Lee RE; Hurdle JG; Liu J; Bruhn DF; Matt T; Scherman MS; Vaddady PK; Zheng Z; Qi J; Akbergenov R; Das S; Madhura DB; Rathi C; Trivedi A; Villellas C; Lee RB; Rakesh ; Waidyarachchi SL; Sun D; McNeil MR; Ainsa JA; Boshoff HI; Gonzalez-Juarrero M; Meibohm B; Böttger EC; Lenaerts AJ
Nat Med; 2014 Feb; 20(2):152-158. PubMed ID: 24464186
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
25. Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Arena A; Arrieta F; Rebolledo JC; Smith DK
Antimicrob Agents Chemother; 2014 Nov; 58(11):6828-36. PubMed ID: 25182645
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
27. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
Kang S; Kim RY; Seo MJ; Lee S; Kim YM; Seo M; Seo JJ; Ko Y; Choi I; Jang J; Nam J; Park S; Kang H; Kim HJ; Kim J; Ahn S; Pethe K; Nam K; No Z; Kim J
J Med Chem; 2014 Jun; 57(12):5293-305. PubMed ID: 24870926
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.
Narayanaswamy VK; Nayak SK; Pillay M; Prasanna R; Coovadia YM; Odhav B
Chem Biol Drug Des; 2013 Feb; 81(2):219-27. PubMed ID: 23150983
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
[TBL] [Abstract][Full Text] [Related]
31. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
[No Abstract] [Full Text] [Related]
32. 1-(Piperidin-3-yl)thymine amides as inhibitors of
Jian Y; Risseeuw MDP; Froeyen M; Song L; Cappoen D; Cos P; Munier-Lehmann H; van Calenbergh S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1730-1739. PubMed ID: 31822127
[TBL] [Abstract][Full Text] [Related]
33. A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis
Patel N; O'Malley T; Zhang YK; Xia Y; Sunde B; Flint L; Korkegian A; Ioerger TR; Sacchettini J; Alley MRK; Parish T
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674058
[TBL] [Abstract][Full Text] [Related]
34.
Xu J; Wang B; Fu L; Zhu H; Guo S; Huang H; Yin D; Zhang Y; Lu Y
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782992
[TBL] [Abstract][Full Text] [Related]
35. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
Mahajan NS; Dhawale SC
Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
[TBL] [Abstract][Full Text] [Related]
36. Strategies towards the synthesis of anti-tuberculosis drugs.
Rode HB; Lade DM; Grée R; Mainkar PS; Chandrasekhar S
Org Biomol Chem; 2019 Jun; 17(22):5428-5459. PubMed ID: 31111850
[TBL] [Abstract][Full Text] [Related]
37. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.
White EL; Suling WJ; Ross LJ; Seitz LE; Reynolds RC
J Antimicrob Chemother; 2002 Jul; 50(1):111-4. PubMed ID: 12096015
[TBL] [Abstract][Full Text] [Related]
38. A new class of antituberculosis agents.
Jones PB; Parrish NM; Houston TA; Stapon A; Bansal NP; Dick JD; Townsend CA
J Med Chem; 2000 Aug; 43(17):3304-14. PubMed ID: 10966749
[TBL] [Abstract][Full Text] [Related]
39. Identification of lipid metabolism-targeting compounds active against drug-resistant M. tuberculosis.
Singh AK; Karaulia P; Yadav P; Narender T; Singh SP; Sashidhara KV; Pandey AK; Chopra S; Dasgupta A
J Glob Antimicrob Resist; 2016 Dec; 7():26-27. PubMed ID: 27552738
[No Abstract] [Full Text] [Related]
40. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.
Tangallapally RP; Yendapally R; Lee RE; Hevener K; Jones VC; Lenaerts AJ; McNeil MR; Wang Y; Franzblau S; Lee RE
J Med Chem; 2004 Oct; 47(21):5276-83. PubMed ID: 15456272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]